An open-label, randomised, controlled trial on the benefit of hmb, L-arginine, and L-glutamine beverages and locomotion training as supportive care in the treatment of unresectable advanced hepatocellular carcinoma using lenvatinib: Hello study

In this study, we report a randomised, controlled trial (RCT) on the efficacy of HMB/L-arginine/L-glutamine (HMB/Arg/Gln) and locomotion training as supportive care in the treatment of unresectable advanced HCC with lenvatinib.

Source: Clinical Nutrition ESPEN - December 1, 2023 Category: Nutrition Authors: A. Naganuma, F. Makita, R. Sugimoto, M. Kikuchi, K. Furuta, S. Iwamoto, E. Mita, H. Kouno, K. Ario, H. Yatsuhashi, National Hospital Organization Liver Disease Network Group Source Type: research